/sent on behalf of
Brent Fedirchuk
Brent.Fedirchuk(a)umanitoba.ca
Subject: Announcement of NEW Neuroscience-related IMED Graduate course offerings.
I would like to distribute the notice attached as widely as possible to the local Neuroscience academic community (including students). It is announcement of a new suite of 4 Neuroscience graduate courses that are each 1.5 credit hours.
These courses will be offered successively during the 2018 Fall and 2019 Winter academic terms and will replace the IMED7101 and IMED7102 courses (3 credit hours) that have previously been offered.
June 2018
Notice of NEW Neuroscience Graduate Course Offerings
(please post)
Fall Term 2018:
IMED7112 - Fundamental Cellular Neurobiology (Sept - Oct)
IMED7114 - Fundamental Neural Development and Plasticity (Oct - Dec)
Winter Term 2019:
IMED7116 - Fundamental Systems Neuroscience (Jan - Feb)
IMED7118 - Fundamental Neurobiology of Disease (Mar - Apr)
* These 4 new 1.5 credit hour graduate courses will replace:
IMED7101 Fundamentals of Neuroscience I (3 credit hours) and,
IMED7102 Fundamentals of Neuroscience II (3 credit hours)
* None of these courses is a prerequisite to the others, so you may choose to take some, or all
of them.
* These interdisciplinary courses will held at the Rady Faculty of Health Sciences, Bannatyne
Campus
Tuesdays & Thursdays
3:00 - 4:30 p.m.
Dept. Physiology & Pathophysiology Conference Room,
431 BMSB, (4th Floor, Basic Medical Sciences Building)
Rady Faculty of Health Sciences Campus
Registration is open to all graduate students enrolled in any Faculty/College/Department
interested in Neuroscience from the Fort Garry or Bannatyne Campuses, and the St. Boniface
Research Centre.
For more information contact:
Dr. Brent Fedirchuk brent.fedirchuk(a)umanitoba.ca 204 789-3762
Dr. Tabrez Siddiqui (IMED7112) Tabrez.Siddiqui(a)umanitoba.ca 204 318-2564
Dr. Hassan Marzban (IMED7114) Hassan.Marzban(a)umanitoba.ca 204 789-3467
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca>
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies.
******************************************
<http://www.manitobaneuroscience.ca/>
<https://www.facebook.com/manitobaneuroscience/?fref=ts> <https://www.instagram.com/manitobaneuroscience/> <https://twitter.com/manitobaneuro>
Research Presentation
Date: June 28
Time: 11:30-12:30pm
Location: R230, Med Rehab Building (771 McDermot Avenue)
Click here for map<http://umanitoba.ca/about/map/bannatyne/>
Scott Yuzwa, PhD.
Post-doctoral fellow in the labs of Drs. Freda Miller and David Kaplan at the Hospital for Sick Children
Candidate for UMFA position in the Department of Pathology
Topic: "Unraveling cellular communication and cell type diversity in the developing brain"
Kae Normandeau
Administrative Manager
Neuroscience Research Program
SR440 KIAM Building
P: 204-318-2569
E: kae.normandeau(a)umanitoba.ca<mailto:kae.normandeau@umanitoba.ca>
/sent on behalf of
Dr. Paul Fernyhough
Pharmacology & Therapeutics Seminar Series: Dr. Abhishek Banerjee
Date: Thursday, June 21st, 2018
Time: 12:00 pm
Location: 071 Apotex
**Please inform your students that a student lunch will follow at 1pm in room 061 Apotex Centre**
Abhishek Banerjee Ph.D
D.Phil (Oxford)
Marie Curie Fellow and NARSAD Young Investigator,
University of Zurich
Topic: "Beyond E/I Balance: Inhibitory cell-types in Rett Syndrome Pathophysiology "
For more information contact:
Ran-Lee Rhinas 204-789-3553
Kelly Jorundson
Administrative Manager, Division of Neurodegenerative Disorders
St. Boniface Hospital Research
Department of Pharmacology & Therapeutics
University of Manitoba
Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca> or kjorundson(a)sbgh.mb.ca <mailto:Kelly.jorundson@umanitoba.ca>
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies.
/sent on behalf of Paul Fernyhough
Nick Shepel Travel Award
DEADLINE EXTENDED TO: June 22, 2018 - 5 PM
The fund was established by the Division of Neurodegenerative Disorders, St. Boniface Hospital Research Centre, to honor Nick Shepel who was an outstanding researcher, friend and leader. Nick was a true inspiration to his laboratory partners and brought fire, humor, and a desire to always excel. His insistence to always try better has had a permanent effect on his lab mates and peers. Nick led by example and taught that detailed preparation and execution of experiments ensured reliable results.
Purpose: The purpose of this fund shall be to recognize a young investigator (specifically in the neuroscience area) by providing an annual award(s) to support travel costs associated with the applicant's attendance at an upcoming national/international conference where the applicant is presenting a poster or oral presentation. This year, the value of the award may range from $300-600.
Eligibility: At the time of application, students must be registered in the College of Medicine at the University of Manitoba.
· Students must be registered as a full-time graduate student at a Manitoba university.
· A student admitted under the "Provisional Status" may not receive the award during the provisional period.
· Amount of award(s) may vary each year.
· Students must be giving a poster or oral presentation at an upcoming scientific meeting (national/international)
Submission Instructions: Only complete applications will be considered. A complete application consists of the following:
· Introductory letter describing meeting
· Copy of abstract
· Curriculum vitae
· Current GPA, transcripts not needed
· Proposed budget of travel costs
· Submit your completed application materials to:
Paul Fernyhough
Director - Division of Neurodegenerative Disorders
St. Boniface Hospital Research
R4046 - 351 Tache Avenue
Winnipeg, MB R2H 2A6
Email: pfernyhough(a)sbrc.ca
How to apply for reimbursement: Reimbursement will be done in accordance with St. Boniface Hospital travel policies. Only original receipts will be accepted. Copies may be accepted only where proof of submission to another agency is provided. Request for reimbursement must be done within 2 weeks following travel otherwise eligibility may be voided.
Kelly Jorundson
Administrative Manager, Division of Neurodegenerative Disorders
St. Boniface Hospital Research
Department of Pharmacology & Therapeutics
University of Manitoba
Email: kjorund(a)sbrc.ca or kjorundson(a)sbgh.mb.ca <mailto:Kelly.jorundson@umanitoba.ca>
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies.
Dear all,
Please note that Dr. Sare's visit to Winnipeg scheduled for June 18th, 2018 has been cancelled due to a family emergency.
Apologies for inconvenience.
Regards,
Kelly
Kelly Jorundson
Administrative Manager, Division of Neurodegenerative Disorders
St. Boniface Hospital Research
Department of Pharmacology & Therapeutics
University of Manitoba
Email: kjorund(a)sbrc.ca <mailto:kjorund@sbrc.ca> or kjorundson(a)sbgh.mb.ca <mailto:Kelly.jorundson@umanitoba.ca>
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA
This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose. If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited. If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies.
cid:image001.jpg@01D158FE.B69B8D00
/sent on behalf of Susan Zettler
Date: June 7, 2018
Time: 1:30 PM �C 2:30 PM
Location: Samuel N. Cohen Auditorium, St. Boniface Hospital Albrechtsen
Research Centre
Deborah Toiber, PhD
Senior Lecturer
Department of Life Sciences
Ben-Gurion University of the Negev
Beer-Sheva, Israel
Topic: NEUROPROTECTIVE FUNCTIONS FOR THE HISTONE DEACETYLASE SIRT6
Neurodegenerative diseases are caused by the loss of neuronal cells. For
many years, researchers have been trying to find the causes and possible
therapies for the diverse neurodegenerative pathologies. Yet, distinguishing
between the causes and the consequences of neurodegeneration is difficult,
as all the symptoms and markers get tangled in an array of phenotypes. The
most accepted theory of aging is that the accumulation of unrepaired DNA
damage is the main cause: As we age, we accumulate DNA lesions, until we
reach a threshold of irreparable lesions. The histone deacetylase SIRT6 has
been linked to the aging process. SIRT6 knockout mice exhibit an accelerated
aging phenotype and die prematurely. SIRT6 promotes DNA repair, but its
activity declines with age with a concomitant accumulation of DNA damage. We
report that brain-specific SIRT6-deficient mice survive but present
behavioral defects with major learning impairments by 4 months of age.
Moreover, the brains of these mice show increased signs of DNA damage, cell
death, and hyperphosphorylated Tau-a critical mark in several
neurodegenerative diseases. Mechanistically, SIRT6 regulates Tau protein
stability and phosphorylation through increased activation of the kinase
GSK3��/��. Finally, SIRT6 mRNA and protein levels are reduced in patients
with Alzheimer's disease. Taken together, our results suggest that SIRT6 is
critical to maintain genomic stability in the brain and that its loss leads
to toxic Tau stability and phosphorylation. Therefore, SIRT6 and its
downstream signaling could be targeted in Alzheimer's disease and
age-related neurodegeneration.
For further information, please contact the CCARM
Administration Office
Tel: 235-3455 email: ccarm(a)sbrc.ca
Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network
Email: kjorund(a)sbrc.ca
Tel: 204.235.3939
Fax: 204.237.4092
St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Tach�� Avenue, Winnipeg, MB R2H 2A6 CANADA
This email and any attachments may contain confidential, personal and/or
privileged information intended for a specific individual and purpose. If
you are not the intended recipient, you are hereby notified that any
disclosure, copying, retaining, distribution, access, use or modification of
the contents of this e-mailed information is strictly prohibited. If you
receive this communication in error, please notify the sender immediately
and delete or destroy the email message and any attachments or copies.
******************************************
<http://www.manitobaneuroscience.ca/> cid:image003.jpg@01D159B3.9F0B9710
<https://www.facebook.com/manitobaneuroscience/?fref=ts>
cid:image007.png@01D29326.7E26D480
<https://www.instagram.com/manitobaneuroscience/> cid:image009.jpg@01D29326.
7E26D480 <https://twitter.com/manitobaneuro>
cid:image010.png@01D29326.7E26D480